1.05671

Lithium carbonate

EMPROVE^® ESSENTIAL, Ph. Eur., BP, USP

• 동의어(들): Lithium carbonate
• 실험식(Hill 표기법): CLi₂O₃
• CAS Number: 554-13-2
• Molecular Weight: 73.89
• MDL number: MFCD00011084
• UNSPSC 코드: 12352302
• EC 인덱스 번호: 209-062-5

속성

• Agency: BP; Ph. Eur.; USP
• Quality Level: 500
• 설명: EMPROVE^® ESSENTIAL Ph Eur,BP,USP
• 제품 라인: EMPROVE^® ESSENTIAL
• 형태: solid
• 효능: 525 mg/kg LD₅₀, oral (Rat)
• pH: 10-11 (20 °C, 5 g/L in H₂O)
• mp: 720 °C
• density: 2.1 g/cm³ at 20 °C
• 응용 분야: pharmaceutical; solid formulation
• 저장 온도: 15-25°C
• InChI: 1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2
• InChI key: XGZVUEUWXADBQD-UHFFFAOYSA-L

설명

일반 설명

Finding the right excipient that matches your needs as well as regulatory demands can be a complicated challenge in formulation. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our EMPROVE^® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC^® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

애플리케이션

Lithium carbonate Emprove^® Essential is mainly used in highly regulated pharmaceutical applications.

법적 정보

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

안전성 정보

• 픽토그램: GHS07
• 신호어: Warning
• 유해 및 위험 성명서: H302 - H319
• 예방조치 성명서: P264 - P270 - P280 - P301 + P312 - P305 + P351 + P338 - P337 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Eye Irrit. 2
• Storage Class Code: 13 - Non Combustible Solids
• WGK: WGK 1
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable